1 |
Paulus, W. and Jellinger, K.: The neuropathologic basis of different clinical subgroups of Parkinson's disease. J. Neuropathol. Exp. Neurol. 50, 743-755. (1991)
DOI
|
2 |
Shen, L. and Zhang, J.: Ginsenoside increases ischemia-induced cell proliferation and survival in the dentate gyrus of adult gerbils. Neurosci. Lett. 344, 1-4 (2003)
DOI
ScienceOn
|
3 |
Persson, J., Bringlov, E., Nilsson, L. G. and Nyberg, L.: The memory-enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers. Psychopharmacology 172, 430-434 (2004)
DOI
|
4 |
Yun, T. K.: Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16: 53-55 (2001)
|
5 |
Tsang, D., Yeung, H. W., Tso, W. W. and Peck, H.: Ginseng saponins: influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med. 3, 221-224 (1985)
|
6 |
Albin, R. L. and Greenamyre, J. T.: Alternative excitotoxic hypotheses. Neurology 42, 733-738 (1992)
DOI
|
7 |
Murer, M. G., Dziewczapolski, G., Menalled, L. B., Garcia, M. C., Agid, Y., Gershanik, O. and Raisman-Vozari, R.: Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Ann. Neurol. 43, 561-575 (1998)
DOI
ScienceOn
|
8 |
Lai, C. T. and Yu, P. H.: Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced ctoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells: Effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53, 363-372 (1997)
DOI
ScienceOn
|
9 |
Chu, G. X. and Chen, X.: Anti-lipid peroxidation and protection of ginsenosides against cerebral ischemia-reperfusion in rats. Zhongguo Yao Li Xue Bao 11, 119-123 (1990)
|
10 |
Sugaya, A., Yuzurihara, M., Tsuda, T., Yasuda, K., Kajiwara, K. and Sugaya, A. E.: Proliferative effect of ginseng saponin on neurite extension of primary cultured neurons of the rat cerebral cortex. J. Ethnopharmacol. 22,173-181(1988)
DOI
ScienceOn
|
11 |
Salim, K. N., McEven, B. S. and Choa, H. M.: Ginsenoside regulates ChAT, NGF and trkA mRNA expression in the rat brain. Brain Res. Mol. Brain Res. 47, 177-182 (1997)
DOI
ScienceOn
|
12 |
Sattler, R. and Tymiansky, M.: Molecular mechanism of calcium dependent excitotoxicity, J. Mol. Med. 78, 3-13 (2000)
DOI
ScienceOn
|
13 |
Radad, K., Gille, G., Moldzio, R., Saito, H. and Rausch, W. D.: Ginsenosides and effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021, 41-53 (2004)
DOI
ScienceOn
|
14 |
Itoh, T., Zang, Y. F., Murai, S. and Saito, H.: Effects of Panax ginseng root on the vertical and horizontal motor activities and on brain monoamine-related substances in mice. Planta Med. 55, 429-433 (1989)
DOI
ScienceOn
|
15 |
Quinn, N., Parkes, D., Janota, I. and Marsden, C. D.: Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Mov. Disord. 1, 65-68. (1986)
DOI
ScienceOn
|
16 |
Reichmann, H.: Long-term treatment with dopamine agonists in idiopathic Parkinson's disease. J. Neurol. 247 [Suppl 4], 17-19 (2000)
DOI
ScienceOn
|
17 |
Lipton, S. A. and Rosenberg, P. A.: Excitatory amino acids as a final common pathway for neurologic disorders. Engl. J. Med. 330, 613-622 (1994)
DOI
ScienceOn
|
18 |
Yamaguchi, Y., Higashi, M. and Kobayashi, H.: Effects of ginsenosides on impaired performance caused by scopolamine in rats. Eur. J. Pharmacol. 312,149-151 (1996)
DOI
ScienceOn
|
19 |
Wen, T. C., Yoshimura, H., Matsuda, S., Lim, J. H. and Sakanaka, M.: Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol. 91, 15-22 (1996)
DOI
|
20 |
Radad, K., Gille, G. Moldzio R., Saito, H, Ishige K. and Rausch, W. D.: Ginsenosides effects on survival and neurite growth of -affected mesencephalic cells. J. Neural Transm. 111, 37-45 (2004)
DOI
ScienceOn
|
21 |
Olanow, C. W.: A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444 (1993)
DOI
ScienceOn
|
22 |
Jenner, P., Schapira, A. H. and Marsden, C. D.: New insights into the cause of Parkinson's disease. Neurology 42, 2241-2250 (1992)
DOI
|
23 |
Yuan, H., Sarre, S., Ebinger, G. and Michotte, Y.: Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Brain Res. 1026, 95-107 (2004)
DOI
ScienceOn
|
24 |
Metman, L. V., Konitsiotis, S. and Chase, T. N.: Pathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what. Mov. Disord. 15, 3-8 (2000)
DOI
ScienceOn
|
25 |
Ling, Z. D., Pieri, S. C. and Carvey, P. M.: Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons. Clin. Neuropharmacol. 19, 360-365 (1996)
DOI
ScienceOn
|
26 |
Mytilineou, C., Han, S. K. and Cohen, G.: Toxic and protective effects of L-dopa on mesencephalic cell cultures. J. Neurochem. 61, 1470-1478 (1993)
DOI
|
27 |
Ferrario, J. E., Delfino, M. A., Stefano, A. V., Zbarsky, V., Douhou, A., Murer, M. G., Raisman-Vozari, R. and Gershanik, O. S.: Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process. Neurosc.i Res. 47, 431-436 (2003)
DOI
ScienceOn
|
28 |
Spina, M. B. and Cohen, G.: Exposure of striatal synaptosomes to L-dopa increases levels of oxidized glutathione. J. Pharmacol. Exp. Ther. 247, 502-507 (1988)
|
29 |
Birkmayer, W. and Hornykiewicz, O.: The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism.. Wien. Klin. Wochenschr. 113, 851-854 (1961)
|
30 |
Chase, T. N., Mouradian, M. M. and Engber, T. M.: Motor response complications and the function of striatal efferent systems. Neurology 4, 23-27 (1993)
|
31 |
Nutt, J. G.: Clinical pharmacology of levodopa-induced dyskinesia. Ann. Neurol. 47, 160-164 (2000)
|
32 |
Kebabian, J. W. and Calne, D. B.: Multiple receptors for dopamine. Nature 277, 93-96 (1979)
DOI
ScienceOn
|
33 |
Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. and Caron, M. G.: Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225 (1998)
DOI
|
34 |
Sokoloff, P. and Schwartz, J. C.: Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16, 270-275 (1995)
DOI
ScienceOn
|
35 |
Zigmond, M. J., Hastings, T. G. and Perez, R. G.: Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? Parkinsonism Rel. Disord. 8, 389-393 (2002)
DOI
ScienceOn
|
36 |
Foley, P., Gerlach, M., Double, K. L. and Riederer, P.: Dopamine receptor agonists in the therapy of Parkinson's disease. J. Neural Transm. 111, 1375-1446 (2004)
DOI
ScienceOn
|
37 |
Hefti, F., Melamed, E., Bhawan, J. and Wurtman, R.: Long-term administration of L.dopa does not damage dopaminergic neurons in the mouse. Neurology 31, 1194-1195 (1981)
DOI
|
38 |
Perry, T. L., Yong, V. W., Ito, M., Foulks, J. G., Wall, R. A., Godin, D. V. and Clavier, R. M.: Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J. Neurochem. 43, 990-993 (1984)
DOI
|
39 |
Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, M. and Kakizaki, A.: Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369, 23-32. (1999)
DOI
ScienceOn
|
40 |
Blumenthal, M.: Asian ginseng: potential therapeutic uses. Adv. Nurse Pract. 2, 26-28 (2001)
|
41 |
Pardo, B., Mena, M. A. and de Yebenes, J. G.: L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells. J. Neurochem. 64, 576-582 (1995)
DOI
ScienceOn
|
42 |
Pedros, R. and Soares-da-Silva, P.: Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br. J. Pharmacol. 137, 1305-1313 (2002)
DOI
ScienceOn
|
43 |
Rhim, H., Kim, H., Lee, D. Y., Oh, T. H. and Nah, S. Y.: Ginseng and ginsenoside Rg3, a newly identical active ingredient of ginseng, modulate channel currents in rat sensory neurons. Eur. J. Pharmacol. 463, 151-158 (2002)
|
44 |
Muriel, M. P., Bernard, V., Levey, A. I., Laribi, O., Abrous, D. N., Agid, Y., Bloch, B. and Hirsch, E. C.: Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann. Neurol. 46, 103-111 (1999)
DOI
ScienceOn
|
45 |
Muriel, M. P., Orieux, G. and Hirsch, E. C.: Levodopa but not ropinirole induces and internalization of D1 dopamine receptors in parkinsonian rats. Mov. Disord. 17, 1174-1179 (2002)
DOI
ScienceOn
|
46 |
Noverino, E., Amato, M. and Izzo, A. A.: The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 71: 1-5 (2000)
DOI
ScienceOn
|
47 |
Wen, T. C., Yoshimura, H., Matsuda, S., Lim, J. H. and Sakanaka, M.: Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol. 91, 15-22 (1996)
DOI
|
48 |
Lim, J. H., Wen, T. C., Matsuda, S., Tanaka, J., Maeda, N., Peng, H., Aburaya, J., Ishihara, K. and Sakanaka, M.: Protection of ischaemic hippocampal neurons by ginsenosides , a main ingredient of ginseng root. Neurosci. Res. 28, 191-200 (1997)
DOI
ScienceOn
|
49 |
Liu, C. X. and Xiao, P. G.: Recent advances on ginseng research in China. J. Ethnopharmacol. 36, 27-38 (1992)
DOI
ScienceOn
|
50 |
Jenner, P.: Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease. Curr. Opin. Neurol. 16, 3-7 (2003)
|
51 |
Pirtosek, Z. and Flisar, D.: Neuroprotection and dopamine agonists. Adv. Exp. Med. Biol. 541, 55-74 (2004)
|
52 |
Gille, G., Rausch, W. D., Hung, S. T., Moldzio, R., Janetzky, B., Hundemer, H. P., Kolter, T. and Reichmann, H.: Pergolide protects dopaminergic neurons in primary culture under stress conditions. J. Neural Transm. 109, 633-643 (2002)
DOI
ScienceOn
|
53 |
Bonuccelli, U.: Comparing dopamine agonists in Parkinson's disease. Curr. Opin. Neurol. 16, 13-19 (2003)
DOI
ScienceOn
|
54 |
Le, W. D. and Jankovic, J.: Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Ageing 18, 389-296 (2001)
DOI
ScienceOn
|
55 |
Rudakewich, M., Ba, F. and Benishin, C. G.: Neurotrophic and neuroprotective actions of ginsenosides and . Planta Med . 67, 533-537 (2001)
DOI
ScienceOn
|
56 |
Kim, H. S., Zhang, Y. H., Fang, L. H. and Lee, M. K.: Effects of ginsenosides on bovine adrenal tyrosine hydroxylase. J. Ethnopharmacol. 66, 107-111 (1999)
DOI
ScienceOn
|
57 |
Bliss, T. V. and Collingridge, G. L.: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39 (1993)
DOI
ScienceOn
|
58 |
Tyler, V. E.: The Honest Herbal-A Sensible Guide to the Use of Herbs and Related Remedies. Third ed. The Haworth Press, New York (1993)
|
59 |
O'Hara, M., Kiefer, D., Farrell, K. and Kemper K.: A review of 12 commonly used medicinal herbs. Arch Fam Med 7, 523-536 (1998)
DOI
ScienceOn
|
60 |
Himi, T., Saito, H. and Nishiyama, N.: Effects of ginseng saponins on the survival of cerebral cortex neurons in cell cultures. Chem. Pharm. Bull. (Tokyo) 37, 481-484 (1989)
DOI
ScienceOn
|
61 |
Van Kampen, J., Robertson, H., Hagg, T. and Drobitch, R.: Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp. Neurol. 184, 21-29 (2003)
|
62 |
Mizumaki, Y., Kurimoto, M., Hirashima, Y., Nishijima, M., Kamiyama, H., Nagai, S., Takaku, A., Sugihara, K., Shimizu, M. and Endo, S.: Lipophilic fraction of Panax ginseng induces neuronal differentiation of PC12 cells and promotes neuronal survival of rat cortical neurons by protein kinase C dependent manner. Brain Res. 20, 254-260 (2002)
|
63 |
Kim, Y. C., Kim, S. R., Markelonis, G. J. and Oh, T. H.: Ginsenosides protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res. 4, 426-432 (1998)
|
64 |
Benishin, C. G.: Actions of ginsenoside on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21, 1-5 (1992)
DOI
ScienceOn
|
65 |
Chun, C. X., Gui, Z. Y., An, Z. L., Chun, H., Ying, C., Min, C. L., Fang, F., Can, Z. Y. and Hui, Z. C.: Ginsenoside attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur. J. Pharmacol. 473, 1-7 (2003)
DOI
ScienceOn
|
66 |
Kim, E. H., Jang, M. H., Shin, M. C., Shin, M. S. and Kim, C. J.: Protective effect of aqueous extract of Ginseng radix against 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 cells. Biol. Pharm. Bull. 26, 1668-1673 (2003)
DOI
ScienceOn
|
67 |
Chen, X. C., Chen, Y., Zhu, Y. G., Fang, F. and Chen, L. M.: Protective effect of ginsenoside against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol. Sin. 23, 829-834 (2002)
|
68 |
Rodriguez, M. C., Obeso, J. A. and Olanow, C. W.: Subthalamic nucleus mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44, 175-188 (1998)
DOI
|
69 |
Malenka, R. C. and Nicoll R. A.: NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanism. Trends Neurosci. 16, 521-527 (1993)
DOI
ScienceOn
|
70 |
Kim, H. S., Hong, Y. T., Oh, K. W., Seong, Y. H., Rheu, H. M. and Cho, D. H.: Inhibition by ginsenosides and of methamphetamine-induced hypersensitivity, conditioned place preference and post-synaptic dopamine receptor supersensitivity on mice. Gen. Pharmacol. 30, 783-789 (1998)
DOI
ScienceOn
|
71 |
Plaitakis, A. and Shashidharan, P.: Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247. 1125-1135 (2000)
|
72 |
Said, S. I., Pakbaz, H., Berisha, H. I. and Raza, S.: NMDA receptor activation: critical role in oxidant tissue injury. Free Radic. Bio. Med. 28, 1300-1302 (2000)
DOI
ScienceOn
|
73 |
Doble, A.: The role of excitotoxicity in neurodegenerative disese: implication for therapy. Pharmacol. Ther. 81, 163-221 (1999)
DOI
ScienceOn
|
74 |
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T. and Kagawa, Y.: Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455 (1989)
DOI
ScienceOn
|
75 |
Mook-Jung, I., Hong, H. S., Boo, J. H., Lee, K. H., Yun, S. H., Cheong, M. Y., Joo, I., Huh, K. and Jung, M. W.: Ginsenoside and improve spatial learning and increase hippocampal synaptophysin level in mice. J. Neurosci. Res. 63, 509-915 (2001)
DOI
ScienceOn
|
76 |
Terasawa, K., Shimada, Y. and Kita, T.: Choto-san in the treatment of vascular dementia: a double blind, placebo-controlled study. Phytomedicine 4,15-22 (1997)
DOI
ScienceOn
|
77 |
Kim, H. S., Kang, J. G., Seong, Y. H., Nam, K. Y. and Oh, K. W.: Blockade by ginseng total saponins of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 50, 23-27 (1995)
DOI
ScienceOn
|
78 |
Kurimoto, H., Nishijo, H., Uwano, T., Yamaguchi, H., Zhong, Y. M., Kawanishi, K. and Ono, T.: Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats. Physiol. Behav. 82,345-355 (2004)
DOI
ScienceOn
|
79 |
D'Angelo, L., Grimaldi, R., Caravaggi, M., Marcoli, M., Perucca, E., Lecchini, S., Frigo, G.M. and Crema, A.: A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J. Ethnopharmacol. 16, 15-22 (1986)
DOI
ScienceOn
|
80 |
Kim, H. S., Kang, J. G., Seong, Y. H., Nam, K. Y. and Oh, K. W.: Blockade by ginseng total saponins of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 50, 23-27 (1995)
DOI
ScienceOn
|
81 |
Gerlach, M., Double, K., Arzberger, T., Leblhuber, F., Tatschner, T. and Riederer, P.: Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J. Neural Transm. 110, 1119-1127 (2003)
DOI
ScienceOn
|
82 |
Kennedy, D. O. and Scholey, A. B.: Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol. Biochem. Behav. 75, 687-700 (2003)
DOI
ScienceOn
|
83 |
Fahn, S. and Cohen, G.: the oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32, 804-812 (1992)
DOI
ScienceOn
|
84 |
Sala, F., Mulet, J., Choi, S., Jung, S. Y., Nah, S. Y., Rhim, H., Valor, L. M., Criado, M. and Sala, S.: Effects of ginsenoside on human neuronal nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 301, 1052-1059 (2002)
DOI
ScienceOn
|
85 |
Dziewczapolski, G., Murer, G., Agid Y., Gershanik, O. and Raisman-Vozari, R.: Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats. Neuroreport 8, 975-979 (1997)
DOI
ScienceOn
|
86 |
Shim, I., Won, J., Song, J., Kim, S. E. and Huh, S.: Modulatory effect of ginseng total saponins on dopamine release and tyrosine hydroxylase gene expression induced by nicotine in the mouse. J. Ethnopharmacol. 70, 161-169 (2000)
DOI
ScienceOn
|
87 |
Petkov, V.: Effect of ginseng on the brain biogenic monoamines and 3',5'-AMP system. Experiments on rats. Arzneimittelforschung 28, 388-393 (1978)
|
88 |
Kimura, T., Saunders, P. A., Kim, H. S., Rheu, H. M., Oh, K. W. and Ho, I. K.: Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. Gen. Pharmacol. 25, 193-199 (1994)
DOI
ScienceOn
|
89 |
Choi, S. E., Choi, S., Lee, J. H., Whiting, P. J., Lee, S. M. and Nah, S. Y.: Effects of ginsenosides on GABA(A) receptor channels expressed in Xenopus oocytes. Arch. Pharm. Res. 26, 28-33 (2003)
DOI
ScienceOn
|
90 |
Kim, H. S., Kang, J. G. and Oh, K. W.: Inhibition by ginseng total saponins of the development of morphine reverse tolerance and dopamine receptor supersensitivity in mice. Gen. Pharmacol. 26,1071-1076 (1995)
DOI
ScienceOn
|
91 |
Wang, A., Cao, Y., Wang, Y., Zhao, R. and Liu, C.: Effects of Chinese ginseng root and stem-leaf saponins on learning, memory and biogenic monoamines of brain in rats. Zhongguo Zhong Yao Za Zhi 20, 493-495 (1995)
|